Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
G R FosterHoward C Thomas

Abstract

The effects of chronic hepatitis C virus (HCV) infection, in the absence of cirrhosis, on patients' quality of life was assessed using the short form 36 (SF36) symptomatology questionnaire. Patients with chronic hepatitis C were polysymptomatic and had significant reductions in their SF36 scores for all of the modalities tested. Patients with chronic hepatitis B virus (HBV) infection showed a reduction in the SF36 scores that assessed mental functions, but they had no decrease in the scores that measured physical symptoms, indicating that the symptoms associated with chronic HCV infection are qualitatively different from those associated with chronic HBV infection. Patients with chronic HCV infection who had used intravenous drugs in the past had the greatest impairment in quality-of-life scores, but the reduction in quality-of-life scores was still found in patients who had never used drugs. The reduction in quality of life could not be attributed to the degree of liver inflammation or to the mode of acquisition of the infection. Hence, chronic infection with HCV per se gives rise to physical symptoms that reduce the quality of life of infected patients.

References

Jun 1, 1991·Journal of Medical Virology·J K DaleS E Straus
Jan 1, 1995·Journal of Viral Hepatitis·D J MutimerJ M Neuberger
Jun 1, 1995·Journal of Hepatology·K IshakR N MacSween
Jun 1, 1995·The New England Journal of Medicine·M J TongR L Co
Nov 1, 1994·The American Journal of Psychiatry·J D LipsitzJ M Gorman
May 29, 1993·BMJ : British Medical Journal·C JenkinsonL Wright
Sep 1, 1995·Addictive Behaviors·J C KendallG E Bigelow
Jan 1, 1997·Journal of Viral Hepatitis·Y MiyakawaM Mayumi
Jan 1, 1997·Journal of Viral Hepatitis·S J Hadziyannis
Jan 1, 1997·Journal of Viral Hepatitis·R Lechler, F M Marelli-Berg

❮ Previous
Next ❯

Citations

Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H L Bonkovsky, J M Woolley
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R S Koff
Jul 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J E WareG L Davis
Feb 3, 2007·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Camelia ProtopopescuMaria-Patrizia Carrieri
Apr 23, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Jeffrey W KwanRamsey C Cheung
Jul 10, 2010·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Zhao-Jin ChenBee-Choo Tai
May 12, 2009·International Urology and Nephrology·Baris AfsarNurhan F Ozdemir
Jun 1, 2006·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Hla-Hla TheinGregory J Dore
Sep 23, 2008·Journal of General Internal Medicine·Erik J GroesslSamuel B Ho
May 5, 2005·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G BianchiM Zoli
Jan 4, 2001·International Journal of Nursing Studies·M GlackenV Coates
Feb 13, 2001·Journal of Psychosomatic Research·M M DwightW J Katon
Feb 24, 2001·Journal of Hepatology·J G McHutchisonUNKNOWN Hepatitis Interventional Therapy Group
Feb 28, 2002·Journal of Hepatology·Robert J FontanaAnna S F Lok
Feb 28, 2002·Journal of Hepatology·Daniel M FortonHoward C Thomas
Jun 5, 2002·Journal of Hepatology·Patrice CacoubUNKNOWN Multivirc Group
Aug 15, 2002·Journal of Hepatology·Ludwig KramerPeter Ferenci
Jul 23, 2003·Journal of Hepatology·Juan CórdobaJaume Guardia
Jul 23, 2003·Journal of Hepatology·Daniel M FortonSimon D Taylor-Robinson
Jan 6, 2000·Journal of Hepatology·H C ThomasS D Taylor-Robinson
Apr 18, 2003·Archives of Medical Research·Juan Fernando Gallegos-OrozcoDavid Kershenobich
May 30, 2001·Journal of Clinical Epidemiology·G UnalR A de Man
Oct 13, 2000·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G BianchiG Marchesini
May 3, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G BianchiG Marchesini
Jan 8, 2009·International Journal of Technology Assessment in Health Care·Debbie Hartwell, Jonathan Shepherd
Feb 3, 2005·Journal of the International Neuropsychological Society : JINS·Robin C HilsabeckWilliam Perry
May 29, 2002·Alimentary Pharmacology & Therapeutics·M R KrausM Scheurlen
Dec 15, 2000·Journal of Viral Hepatitis·A S GershonE J Heathcote
Mar 6, 2002·Journal of Viral Hepatitis·Graham R Foster
Jun 26, 2002·Journal of Viral Hepatitis·T PoynardUNKNOWN Multivirc group
May 10, 2002·Journal of Gastroenterology and Hepatology·Hans Glise, Ingela Wiklund
Apr 23, 2002·Journal of Gastroenterology and Hepatology·Jennifer McDonaldSonja Gluseska
May 2, 2002·Journal of Gastroenterology and Hepatology·Gregory J DoreJohn M Kaldor
May 2, 2002·Journal of Gastroenterology and Hepatology·Winita Hardikar
Jun 11, 2003·Journal of Gastroenterology and Hepatology·Sandra M GiffordMark Stoove
Dec 17, 2003·Journal of Gastroenterology and Hepatology·Hla-Hla TheinGregory J Dore
Jun 16, 2001·Transfusion·A Pereira
Aug 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J F CadranelF Degos
May 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D ZdilarZ M Younossi
Feb 5, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Daniel M FortonSimon D Taylor-Robinson
Feb 5, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robin C HilsabeckTarek I Hassanein
Mar 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David BernsteinJesse Green
Jul 7, 2001·The New England Journal of Medicine·G M Lauer, B D Walker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Herbert L Bonkovsky, J M Woolley
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
A J RodgerN Crofts
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
J E WareG L Davis
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Daniel M FortonSimon D Taylor-Robinson
© 2021 Meta ULC. All rights reserved